Brief: Painreform Provides Year-End Business Update And Reports Progress Towards Commencing Phase 3 Trial Of Prf-110 For Non-Opiate Post-Operative Pain Relief
18/03/2021 13:16
March 18 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM PROVIDES YEAR-END BUSINESS UPDATE AND REPORTS
PROGRESS TOWARDS COMMENCING PHASE 3 TRIAL OF PRF-110 FOR
NON-OPIATE POST-OPERATIVE PAIN RELIEF
* PAINREFORM LTD - PLAN TO COMMENCE SECOND PHASE 3 TRIAL FOR
TREATMENT OF HERNIA
* PAINREFORM LTD - NOW HAVE A CASH RUNWAY OF MORE THAN 12
MONTHS
Source text for Eikon: ID:nGNX9P8b72
Further company coverage: PRFX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne